These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28326265)

  • 41. Percutaneous Image-guided Thermal Ablation for Renal Cell Carcinoma.
    Fujimori M; Yamanaka T; Sugino Y; Matsushita N; Sakuma H
    Interv Radiol (Higashimatsuyama); 2020 Jun; 5(2):32-42. PubMed ID: 36284654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of localised renal cell carcinoma.
    Van Poppel H; Becker F; Cadeddu JA; Gill IS; Janetschek G; Jewett MA; Laguna MP; Marberger M; Montorsi F; Polascik TJ; Ukimura O; Zhu G
    Eur Urol; 2011 Oct; 60(4):662-72. PubMed ID: 21726933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery.
    Ghavamian R; Cheville JC; Lohse CM; Weaver AL; Zincke H; Blute ML
    J Urol; 2002 Aug; 168(2):454-9. PubMed ID: 12131287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiofrequency ablation of renal tumors.
    Mahnken AH; Günther RW; Tacke J
    Eur Radiol; 2004 Aug; 14(8):1449-55. PubMed ID: 15150668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nephron sparing surgery for renal tumors: indications, techniques and outcomes.
    Uzzo RG; Novick AC
    J Urol; 2001 Jul; 166(1):6-18. PubMed ID: 11435813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and Efficacy of Percutaneous Image-guided Cryoablation of Completely Endophytic Renal Masses.
    Murray CA; Welch BT; Schmit GD; Schmitz JJ; Weisbrod AJ; Callstrom MR; Welch TL; Thompson RH; Kurup AN; Boorjian SA; Atwell TD
    Urology; 2019 Nov; 133():151-156. PubMed ID: 31415781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes After Cryoablation Versus Partial Nephrectomy for Sporadic Renal Tumors in a Solitary Kidney: A Propensity Score Analysis.
    Bhindi B; Mason RJ; Haddad MM; Boorjian SA; Leibovich BC; Atwell TD; Weisbrod AJ; Schmit GD; Thompson RH
    Eur Urol; 2018 Feb; 73(2):254-259. PubMed ID: 28967553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Laparoscopic and partial nephrectomy.
    Novick AC
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6322S-7S. PubMed ID: 15448025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging.
    Miki K; Shimomura T; Yamada H; Kishimoto K; Ohishi Y; Harada J; Egawa S
    Int J Urol; 2006 Jul; 13(7):880-4. PubMed ID: 16882047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contrast-enhanced Computed Tomography-Guided Percutaneous Cryoablation of Renal Cell Carcinoma in a Renal Allograft: First Case in Asia.
    Tsuboi I; Araki M; Fujiwara H; Iguchi T; Hiraki T; Arichi N; Kawamura K; Maruyama Y; Mitsui Y; Sadahira T; Kubota R; Nishimura S; Sako T; Takamoto A; Wada K; Kobayashi Y; Watanabe T; Yanai H; Kitagawa M; Tanabe K; Sugiyama H; Wada J; Shiina H; Kanazawa S; Nasu Y
    Acta Med Okayama; 2019 Jun; 73(3):269-272. PubMed ID: 31235976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ablation of kidney tumors.
    Karam JA; Ahrar K; Matin SF
    Surg Oncol Clin N Am; 2011 Apr; 20(2):341-53, viii. PubMed ID: 21377587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
    Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ
    Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cryoablation for the Treatment of Kidney Cancer: Comparison With Other Treatment Modalities and Review of Current Treatment.
    Bisbee CA; Zhang J; Owens J; Hussain S
    Cureus; 2022 Nov; 14(11):e31195. PubMed ID: 36505146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost comparison of nephron-sparing treatments for cT1a renal masses.
    Castle SM; Gorbatiy V; Avallone MA; Eldefrawy A; Caulton DE; Leveillee RJ
    Urol Oncol; 2013 Oct; 31(7):1327-32. PubMed ID: 22361086
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery.
    Butler BP; Novick AC; Miller DP; Campbell SA; Licht MR
    Urology; 1995 Jan; 45(1):34-40; discussion 40-1. PubMed ID: 7817478
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes of radiofrequency ablation for kidney cancer.
    Park S; Cadeddu JA
    Cancer Control; 2007 Jul; 14(3):205-10. PubMed ID: 17615525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Irreversible Electroporation (IRE) in Renal Tumors.
    Narayanan G; Doshi MH
    Curr Urol Rep; 2016 Feb; 17(2):15. PubMed ID: 26769468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cryoablation of small kidney tumors.
    Zondervan PJ; Buijs M; de la Rosette JJ; van Delden O; van Lienden K; Laguna MP
    Int J Surg; 2016 Dec; 36(Pt C):533-540. PubMed ID: 27500963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ablative Therapy for Small Renal Masses.
    Taylor BL; Stavropoulos SW; Guzzo TJ
    Urol Clin North Am; 2017 May; 44(2):223-231. PubMed ID: 28411914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oncologic outcomes using real-time peripheral thermometry-guided radiofrequency ablation of small renal masses.
    Leveillee RJ; Castle SM; Gorbatiy V; Salas N; Narayanan G; Morillo-Burgos G; Jorda M; Faraday MM
    J Endourol; 2013 Apr; 27(4):480-9. PubMed ID: 23098088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.